Product Dossier
CIPRAMIL
Product Dossier for CIPRAMIL (citalopram hydrobromide, Lundbeck). ARTG record, PBS listing, PBAC outcomes — compiled by arcimedes.
- Sponsor: Lundbeck
- Active ingredient: citalopram hydrobromide
- Therapeutic area: Psychiatry
- Related brand: APO-CITALOPRAM
- Same area: REXULTI
- Same area: NICORETTE
What it is
CIPRAMIL is a citalopram hydrobromide 20 mg tablet formulation registered on the Australian Register of Therapeutic Goods (ARTG 61164).
PBS listing
CIPRAMIL 20 mg tablets are listed on the PBS with a restriction type requiring authority. The ex-manufacturer price is A$14.75.
Regulatory history
CIPRAMIL was first listed on the ARTG on 9 December 1997.